TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/10/21 18:18 | 3/8/21 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Shenouda Maged | NY | O | CFO | S.dm | -355 | 35.45 | 0 | -10 | -82 | 2 | D | ||||||||||||||
2/16/21 17:08 | 2/11/21 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Shenouda Maged | NY | O | CFO | S.d | -51 | 35.39 | 0 | -1 | -39 | 2 | D | ||||||||||||||
2/10/21 19:25 | 2/8/21 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Shenouda Maged | NY | O | CFO | S.dm | -400 | 35.17 | 0 | -11 | -84 | 2 | D | ||||||||||||||
2/4/21 17:38 | 2/2/21 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Shenouda Maged | NY | O | CFO | S.dm | -112 | 35.04 | 0 | -3 | -59 | 2 | D | ||||||||||||||
1/29/21 17:24 | 1/27/21 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Shenouda Maged | NY | O | CFO | S.d | -96 | 31.93 | 0 | -3 | -57 | 2 | D | ||||||||||||||
1/26/21 19:28 | 1/22/21 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Shenouda Maged | NY | O | CFO | S.dm | -142 | 35.40 | 0 | -4 | -64 | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |